VRDN-001

· Viridian Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for VRDN-001, covering 2026-02-12 to 2026-08-14. Get the full timeline:

Most recent: Clinical Trial Results: An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301 [Phase 3]